Demark’s Lif welcomes Cancer Plan V

There is good news with the new cancer plan, which focuses on prevention and life with and after cancer. There is reason to be happy that the possibility of individual access to treatment is improving, and that health data must be used more actively to ensure rapid access to treatment for Danish patients, believes the Danish pharma trade group Lif.

As a citizen of a country where 40% get cancer before they turn 80, and where many more will get cancer in the future, there is reason to be happy about Cancer Plan V, which was presented last Friday.

Both this year and in 2024 the government is investing an additional 400 million kroner ($60.9 million) in fighting cancer. Starting in 2025, 600 million kroner will be set aside annually for the new cancer plan, according to the Copenhagen Post. Some 5 billion kroner has been set aside by the majority government to strengthen the healthcare system, of which a large part has been designated to cancer treatment.